IP Verse

Low Frequency Glatiramer Acetate Therapy

EP2949335

YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.
Application Number
EP15171065A
Filing Date
Aug 19, 2010
Status
Revoked
Apr 27, 2021
Grant Date
Jan 4, 2017
External Links
Slate, Register

Biblio Summary

The patent EP2949335B1 was granted on Jan 4, 2017 by Yeda Research & Development Company, Ltd. The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 7 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MYLAN TEORANTA TRADING AS MYLAN INSTITUTIONALNov 27, 2017INTERVENTION ADMISSIBLE
ALVOGEN IPCO S.A.R.L.Oct 4, 2017ADMISSIBLE
G. L. PHARMA GMBHOct 4, 2017ADMISSIBLE
HEXAL AGOct 4, 2017ADMISSIBLE
SYNTHON B.V.Oct 4, 2017ADMISSIBLE
GENERICS UKOct 3, 2017ADMISSIBLE
GENERICS [UK] LIMITED (TRADING AS MYLAN)Oct 3, 2017ADMISSIBLE

More Opposed Patents of Yeda Research & Development Company, Ltd.

The table below shows the patents of Yeda Research & Development Company, Ltd. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3409286Low Frequency Glatiramer Acetate TherapyAug 12, 20202
EP2630962Low Frequency Glatiramer Acetate TherapyJun 27, 20185

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents